 | • レポートコード：QFJ1-3485 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、120ページ • 納品方法：Eメール（納期：3日） • 産業分類：産業装置 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、がん治療における感染制御の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（放射線療法、免疫療法、伝統的手術、幹細胞移植療法、化学療法、分子標的療法、光力学療法、その他）、用途別市場規模（病院、製薬会社、医療機器会社、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・がん治療における感染制御の市場動向 ・企業の競争状況、市場シェア ・がん治療における感染制御の種類別市場規模と予測2016-2027（放射線療法、免疫療法、伝統的手術、幹細胞移植療法、化学療法、分子標的療法、光力学療法、その他） ・がん治療における感染制御の用途別市場規模と予測2016-2027（病院、製薬会社、医療機器会社、その他） ・がん治療における感染制御の北米市場規模2016-2027（アメリカ、カナダ） ・がん治療における感染制御の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・がん治療における感染制御のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・がん治療における感染制御の中南米市場規模2016-2027（メキシコ、ブラジル） ・がん治療における感染制御の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Kimberly Clark Corporation、3M Healthcare Company、Honeywell International, Inc.、Getinge Group AB、Sterigenics International、Sakura Global Holding Company、Arizant Healthcare Inc.、Nordion、Cisa S.P.A.、Steris Corporation、Nordion, Inc.、Ahlstrom Filtration LLC、Membrana GmbH、Synergy Health, Plc、Advanced Sterilization Products Services, Inc） ・結論 |
Market Analysis and Insights: Global Infection Control in Cancer Therapy Market
The global Infection Control in Cancer Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Infection Control in Cancer Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Infection Control in Cancer Therapy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Infection Control in Cancer Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Infection Control in Cancer Therapy market.
Global Infection Control in Cancer Therapy Scope and Market Size
Infection Control in Cancer Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Infection Control in Cancer Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Radiation Therapy
Immunotherapy
Traditional Surgery
Stem Cell Transplant Therapy
Chemotherapy
Targeted Therapy
Photodynamic Therapy
Other
Segment by Application
Hospital
Pharmaceutical Companies
Medical device companies
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Kimberly Clark Corporation
3M Healthcare Company
Honeywell International, Inc.
Getinge Group AB
Sterigenics International
Sakura Global Holding Company
Arizant Healthcare Inc.
Nordion
Cisa S.P.A.
Steris Corporation
Nordion, Inc.
Ahlstrom Filtration LLC
Membrana GmbH
Synergy Health, Plc
Advanced Sterilization Products Services, Inc
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Infection Control in Cancer Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Radiation Therapy
1.2.3 Immunotherapy
1.2.4 Traditional Surgery
1.2.5 Stem Cell Transplant Therapy
1.2.6 Chemotherapy
1.2.7 Targeted Therapy
1.2.8 Photodynamic Therapy
1.2.9 Other
1.3 Market by Application
1.3.1 Global Infection Control in Cancer Therapy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Pharmaceutical Companies
1.3.4 Medical device companies
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Infection Control in Cancer Therapy Market Perspective (2016-2027)
2.2 Infection Control in Cancer Therapy Growth Trends by Regions
2.2.1 Infection Control in Cancer Therapy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Infection Control in Cancer Therapy Historic Market Share by Regions (2016-2021)
2.2.3 Infection Control in Cancer Therapy Forecasted Market Size by Regions (2022-2027)
2.3 Infection Control in Cancer Therapy Industry Dynamic
2.3.1 Infection Control in Cancer Therapy Market Trends
2.3.2 Infection Control in Cancer Therapy Market Drivers
2.3.3 Infection Control in Cancer Therapy Market Challenges
2.3.4 Infection Control in Cancer Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Infection Control in Cancer Therapy Players by Revenue
3.1.1 Global Top Infection Control in Cancer Therapy Players by Revenue (2016-2021)
3.1.2 Global Infection Control in Cancer Therapy Revenue Market Share by Players (2016-2021)
3.2 Global Infection Control in Cancer Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Infection Control in Cancer Therapy Revenue
3.4 Global Infection Control in Cancer Therapy Market Concentration Ratio
3.4.1 Global Infection Control in Cancer Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Infection Control in Cancer Therapy Revenue in 2020
3.5 Infection Control in Cancer Therapy Key Players Head office and Area Served
3.6 Key Players Infection Control in Cancer Therapy Product Solution and Service
3.7 Date of Enter into Infection Control in Cancer Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Infection Control in Cancer Therapy Breakdown Data by Type
4.1 Global Infection Control in Cancer Therapy Historic Market Size by Type (2016-2021)
4.2 Global Infection Control in Cancer Therapy Forecasted Market Size by Type (2022-2027)
5 Infection Control in Cancer Therapy Breakdown Data by Application
5.1 Global Infection Control in Cancer Therapy Historic Market Size by Application (2016-2021)
5.2 Global Infection Control in Cancer Therapy Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Infection Control in Cancer Therapy Market Size (2016-2027)
6.2 North America Infection Control in Cancer Therapy Market Size by Type
6.2.1 North America Infection Control in Cancer Therapy Market Size by Type (2016-2021)
6.2.2 North America Infection Control in Cancer Therapy Market Size by Type (2022-2027)
6.2.3 North America Infection Control in Cancer Therapy Market Size by Type (2016-2027)
6.3 North America Infection Control in Cancer Therapy Market Size by Application
6.3.1 North America Infection Control in Cancer Therapy Market Size by Application (2016-2021)
6.3.2 North America Infection Control in Cancer Therapy Market Size by Application (2022-2027)
6.3.3 North America Infection Control in Cancer Therapy Market Size by Application (2016-2027)
6.4 North America Infection Control in Cancer Therapy Market Size by Country
6.4.1 North America Infection Control in Cancer Therapy Market Size by Country (2016-2021)
6.4.2 North America Infection Control in Cancer Therapy Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Infection Control in Cancer Therapy Market Size (2016-2027)
7.2 Europe Infection Control in Cancer Therapy Market Size by Type
7.2.1 Europe Infection Control in Cancer Therapy Market Size by Type (2016-2021)
7.2.2 Europe Infection Control in Cancer Therapy Market Size by Type (2022-2027)
7.2.3 Europe Infection Control in Cancer Therapy Market Size by Type (2016-2027)
7.3 Europe Infection Control in Cancer Therapy Market Size by Application
7.3.1 Europe Infection Control in Cancer Therapy Market Size by Application (2016-2021)
7.3.2 Europe Infection Control in Cancer Therapy Market Size by Application (2022-2027)
7.3.3 Europe Infection Control in Cancer Therapy Market Size by Application (2016-2027)
7.4 Europe Infection Control in Cancer Therapy Market Size by Country
7.4.1 Europe Infection Control in Cancer Therapy Market Size by Country (2016-2021)
7.4.2 Europe Infection Control in Cancer Therapy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Infection Control in Cancer Therapy Market Size (2016-2027)
8.2 Asia-Pacific Infection Control in Cancer Therapy Market Size by Type
8.2.1 Asia-Pacific Infection Control in Cancer Therapy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Infection Control in Cancer Therapy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Infection Control in Cancer Therapy Market Size by Type (2016-2027)
8.3 Asia-Pacific Infection Control in Cancer Therapy Market Size by Application
8.3.1 Asia-Pacific Infection Control in Cancer Therapy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Infection Control in Cancer Therapy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Infection Control in Cancer Therapy Market Size by Application (2016-2027)
8.4 Asia-Pacific Infection Control in Cancer Therapy Market Size by Region
8.4.1 Asia-Pacific Infection Control in Cancer Therapy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Infection Control in Cancer Therapy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Infection Control in Cancer Therapy Market Size (2016-2027)
9.2 Latin America Infection Control in Cancer Therapy Market Size by Type
9.2.1 Latin America Infection Control in Cancer Therapy Market Size by Type (2016-2021)
9.2.2 Latin America Infection Control in Cancer Therapy Market Size by Type (2022-2027)
9.2.3 Latin America Infection Control in Cancer Therapy Market Size by Type (2016-2027)
9.3 Latin America Infection Control in Cancer Therapy Market Size by Application
9.3.1 Latin America Infection Control in Cancer Therapy Market Size by Application (2016-2021)
9.3.2 Latin America Infection Control in Cancer Therapy Market Size by Application (2022-2027)
9.3.3 Latin America Infection Control in Cancer Therapy Market Size by Application (2016-2027)
9.4 Latin America Infection Control in Cancer Therapy Market Size by Country
9.4.1 Latin America Infection Control in Cancer Therapy Market Size by Country (2016-2021)
9.4.2 Latin America Infection Control in Cancer Therapy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Infection Control in Cancer Therapy Market Size (2016-2027)
10.2 Middle East & Africa Infection Control in Cancer Therapy Market Size by Type
10.2.1 Middle East & Africa Infection Control in Cancer Therapy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Infection Control in Cancer Therapy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Infection Control in Cancer Therapy Market Size by Type (2016-2027)
10.3 Middle East & Africa Infection Control in Cancer Therapy Market Size by Application
10.3.1 Middle East & Africa Infection Control in Cancer Therapy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Infection Control in Cancer Therapy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Infection Control in Cancer Therapy Market Size by Application (2016-2027)
10.4 Middle East & Africa Infection Control in Cancer Therapy Market Size by Country
10.4.1 Middle East & Africa Infection Control in Cancer Therapy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Infection Control in Cancer Therapy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Kimberly Clark Corporation
11.1.1 Kimberly Clark Corporation Company Details
11.1.2 Kimberly Clark Corporation Business Overview
11.1.3 Kimberly Clark Corporation Infection Control in Cancer Therapy Introduction
11.1.4 Kimberly Clark Corporation Revenue in Infection Control in Cancer Therapy Business (2016-2021)
11.1.5 Kimberly Clark Corporation Recent Development
11.2 3M Healthcare Company
11.2.1 3M Healthcare Company Company Details
11.2.2 3M Healthcare Company Business Overview
11.2.3 3M Healthcare Company Infection Control in Cancer Therapy Introduction
11.2.4 3M Healthcare Company Revenue in Infection Control in Cancer Therapy Business (2016-2021)
11.2.5 3M Healthcare Company Recent Development
11.3 Honeywell International, Inc.
11.3.1 Honeywell International, Inc. Company Details
11.3.2 Honeywell International, Inc. Business Overview
11.3.3 Honeywell International, Inc. Infection Control in Cancer Therapy Introduction
11.3.4 Honeywell International, Inc. Revenue in Infection Control in Cancer Therapy Business (2016-2021)
11.3.5 Honeywell International, Inc. Recent Development
11.4 Getinge Group AB
11.4.1 Getinge Group AB Company Details
11.4.2 Getinge Group AB Business Overview
11.4.3 Getinge Group AB Infection Control in Cancer Therapy Introduction
11.4.4 Getinge Group AB Revenue in Infection Control in Cancer Therapy Business (2016-2021)
11.4.5 Getinge Group AB Recent Development
11.5 Sterigenics International
11.5.1 Sterigenics International Company Details
11.5.2 Sterigenics International Business Overview
11.5.3 Sterigenics International Infection Control in Cancer Therapy Introduction
11.5.4 Sterigenics International Revenue in Infection Control in Cancer Therapy Business (2016-2021)
11.5.5 Sterigenics International Recent Development
11.6 Sakura Global Holding Company
11.6.1 Sakura Global Holding Company Company Details
11.6.2 Sakura Global Holding Company Business Overview
11.6.3 Sakura Global Holding Company Infection Control in Cancer Therapy Introduction
11.6.4 Sakura Global Holding Company Revenue in Infection Control in Cancer Therapy Business (2016-2021)
11.6.5 Sakura Global Holding Company Recent Development
11.7 Arizant Healthcare Inc.
11.7.1 Arizant Healthcare Inc. Company Details
11.7.2 Arizant Healthcare Inc. Business Overview
11.7.3 Arizant Healthcare Inc. Infection Control in Cancer Therapy Introduction
11.7.4 Arizant Healthcare Inc. Revenue in Infection Control in Cancer Therapy Business (2016-2021)
11.7.5 Arizant Healthcare Inc. Recent Development
11.8 Nordion
11.8.1 Nordion Company Details
11.8.2 Nordion Business Overview
11.8.3 Nordion Infection Control in Cancer Therapy Introduction
11.8.4 Nordion Revenue in Infection Control in Cancer Therapy Business (2016-2021)
11.8.5 Nordion Recent Development
11.9 Cisa S.P.A.
11.9.1 Cisa S.P.A. Company Details
11.9.2 Cisa S.P.A. Business Overview
11.9.3 Cisa S.P.A. Infection Control in Cancer Therapy Introduction
11.9.4 Cisa S.P.A. Revenue in Infection Control in Cancer Therapy Business (2016-2021)
11.9.5 Cisa S.P.A. Recent Development
11.10 Steris Corporation
11.10.1 Steris Corporation Company Details
11.10.2 Steris Corporation Business Overview
11.10.3 Steris Corporation Infection Control in Cancer Therapy Introduction
11.10.4 Steris Corporation Revenue in Infection Control in Cancer Therapy Business (2016-2021)
11.10.5 Steris Corporation Recent Development
11.11 Nordion, Inc.
11.11.1 Nordion, Inc. Company Details
11.11.2 Nordion, Inc. Business Overview
11.11.3 Nordion, Inc. Infection Control in Cancer Therapy Introduction
11.11.4 Nordion, Inc. Revenue in Infection Control in Cancer Therapy Business (2016-2021)
11.11.5 Nordion, Inc. Recent Development
11.12 Ahlstrom Filtration LLC
11.12.1 Ahlstrom Filtration LLC Company Details
11.12.2 Ahlstrom Filtration LLC Business Overview
11.12.3 Ahlstrom Filtration LLC Infection Control in Cancer Therapy Introduction
11.12.4 Ahlstrom Filtration LLC Revenue in Infection Control in Cancer Therapy Business (2016-2021)
11.12.5 Ahlstrom Filtration LLC Recent Development
11.13 Membrana GmbH
11.13.1 Membrana GmbH Company Details
11.13.2 Membrana GmbH Business Overview
11.13.3 Membrana GmbH Infection Control in Cancer Therapy Introduction
11.13.4 Membrana GmbH Revenue in Infection Control in Cancer Therapy Business (2016-2021)
11.13.5 Membrana GmbH Recent Development
11.14 Synergy Health, Plc
11.14.1 Synergy Health, Plc Company Details
11.14.2 Synergy Health, Plc Business Overview
11.14.3 Synergy Health, Plc Infection Control in Cancer Therapy Introduction
11.14.4 Synergy Health, Plc Revenue in Infection Control in Cancer Therapy Business (2016-2021)
11.14.5 Synergy Health, Plc Recent Development
11.15 Advanced Sterilization Products Services, Inc
11.15.1 Advanced Sterilization Products Services, Inc Company Details
11.15.2 Advanced Sterilization Products Services, Inc Business Overview
11.15.3 Advanced Sterilization Products Services, Inc Infection Control in Cancer Therapy Introduction
11.15.4 Advanced Sterilization Products Services, Inc Revenue in Infection Control in Cancer Therapy Business (2016-2021)
11.15.5 Advanced Sterilization Products Services, Inc Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Infection Control in Cancer Therapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Radiation Therapy
Table 3. Key Players of Immunotherapy
Table 4. Key Players of Traditional Surgery
Table 5. Key Players of Stem Cell Transplant Therapy
Table 6. Key Players of Chemotherapy
Table 7. Key Players of Targeted Therapy
Table 8. Key Players of Photodynamic Therapy
Table 9. Key Players of Other
Table 10. Global Infection Control in Cancer Therapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Infection Control in Cancer Therapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 12. Global Infection Control in Cancer Therapy Market Size by Regions (2016-2021) & (US$ Million)
Table 13. Global Infection Control in Cancer Therapy Market Share by Regions (2016-2021)
Table 14. Global Infection Control in Cancer Therapy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 15. Global Infection Control in Cancer Therapy Market Share by Regions (2022-2027)
Table 16. Infection Control in Cancer Therapy Market Trends
Table 17. Infection Control in Cancer Therapy Market Drivers
Table 18. Infection Control in Cancer Therapy Market Challenges
Table 19. Infection Control in Cancer Therapy Market Restraints
Table 20. Global Infection Control in Cancer Therapy Revenue by Players (2016-2021) & (US$ Million)
Table 21. Global Infection Control in Cancer Therapy Market Share by Players (2016-2021)
Table 22. Global Top Infection Control in Cancer Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Infection Control in Cancer Therapy as of 2020)
Table 23. Ranking of Global Top Infection Control in Cancer Therapy Companies by Revenue (US$ Million) in 2020
Table 24. Global 5 Largest Players Market Share by Infection Control in Cancer Therapy Revenue (CR5 and HHI) & (2016-2021)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Infection Control in Cancer Therapy Product Solution and Service
Table 27. Date of Enter into Infection Control in Cancer Therapy Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Infection Control in Cancer Therapy Market Size by Type (2016-2021) (US$ Million)
Table 30. Global Infection Control in Cancer Therapy Revenue Market Share by Type (2016-2021)
Table 31. Global Infection Control in Cancer Therapy Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 32. Global Infection Control in Cancer Therapy Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 33. Global Infection Control in Cancer Therapy Market Size Share by Application (2016-2021) & (US$ Million)
Table 34. Global Infection Control in Cancer Therapy Revenue Market Share by Application (2016-2021)
Table 35. Global Infection Control in Cancer Therapy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 36. Global Infection Control in Cancer Therapy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 37. North America Infection Control in Cancer Therapy Market Size by Type (2016-2021) (US$ Million)
Table 38. North America Infection Control in Cancer Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 39. North America Infection Control in Cancer Therapy Market Size by Application (2016-2021) (US$ Million)
Table 40. North America Infection Control in Cancer Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 41. North America Infection Control in Cancer Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 42. North America Infection Control in Cancer Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 43. Europe Infection Control in Cancer Therapy Market Size by Type (2016-2021) (US$ Million)
Table 44. Europe Infection Control in Cancer Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 45. Europe Infection Control in Cancer Therapy Market Size by Application (2016-2021) (US$ Million)
Table 46. Europe Infection Control in Cancer Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 47. Europe Infection Control in Cancer Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 48. Europe Infection Control in Cancer Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Infection Control in Cancer Therapy Market Size by Type (2016-2021) (US$ Million)
Table 50. Asia-Pacific Infection Control in Cancer Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Infection Control in Cancer Therapy Market Size by Application (2016-2021) (US$ Million)
Table 52. Asia-Pacific Infection Control in Cancer Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 53. Asia-Pacific Infection Control in Cancer Therapy Market Size by Region (2016-2021) & (US$ Million)
Table 54. Asia-Pacific Infection Control in Cancer Therapy Market Size by Region (2022-2027) & (US$ Million)
Table 55. Latin America Infection Control in Cancer Therapy Market Size by Type (2016-2021) (US$ Million)
Table 56. Latin America Infection Control in Cancer Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 57. Latin America Infection Control in Cancer Therapy Market Size by Application (2016-2021) (US$ Million)
Table 58. Latin America Infection Control in Cancer Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 59. Latin America Infection Control in Cancer Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 60. Latin America Infection Control in Cancer Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Infection Control in Cancer Therapy Market Size by Type (2016-2021) (US$ Million)
Table 62. Middle East & Africa Infection Control in Cancer Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Infection Control in Cancer Therapy Market Size by Application (2016-2021) (US$ Million)
Table 64. Middle East & Africa Infection Control in Cancer Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 65. Middle East & Africa Infection Control in Cancer Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 66. Middle East & Africa Infection Control in Cancer Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 67. Kimberly Clark Corporation Company Details
Table 68. Kimberly Clark Corporation Business Overview
Table 69. Kimberly Clark Corporation Infection Control in Cancer Therapy Product
Table 70. Kimberly Clark Corporation Revenue in Infection Control in Cancer Therapy Business (2016-2021) & (US$ Million)
Table 71. Kimberly Clark Corporation Recent Development
Table 72. 3M Healthcare Company Company Details
Table 73. 3M Healthcare Company Business Overview
Table 74. 3M Healthcare Company Infection Control in Cancer Therapy Product
Table 75. 3M Healthcare Company Revenue in Infection Control in Cancer Therapy Business (2016-2021) & (US$ Million)
Table 76. 3M Healthcare Company Recent Development
Table 77. Honeywell International, Inc. Company Details
Table 78. Honeywell International, Inc. Business Overview
Table 79. Honeywell International, Inc. Infection Control in Cancer Therapy Product
Table 80. Honeywell International, Inc. Revenue in Infection Control in Cancer Therapy Business (2016-2021) & (US$ Million)
Table 81. Honeywell International, Inc. Recent Development
Table 82. Getinge Group AB Company Details
Table 83. Getinge Group AB Business Overview
Table 84. Getinge Group AB Infection Control in Cancer Therapy Product
Table 85. Getinge Group AB Revenue in Infection Control in Cancer Therapy Business (2016-2021) & (US$ Million)
Table 86. Getinge Group AB Recent Development
Table 87. Sterigenics International Company Details
Table 88. Sterigenics International Business Overview
Table 89. Sterigenics International Infection Control in Cancer Therapy Product
Table 90. Sterigenics International Revenue in Infection Control in Cancer Therapy Business (2016-2021) & (US$ Million)
Table 91. Sterigenics International Recent Development
Table 92. Sakura Global Holding Company Company Details
Table 93. Sakura Global Holding Company Business Overview
Table 94. Sakura Global Holding Company Infection Control in Cancer Therapy Product
Table 95. Sakura Global Holding Company Revenue in Infection Control in Cancer Therapy Business (2016-2021) & (US$ Million)
Table 96. Sakura Global Holding Company Recent Development
Table 97. Arizant Healthcare Inc. Company Details
Table 98. Arizant Healthcare Inc. Business Overview
Table 99. Arizant Healthcare Inc. Infection Control in Cancer Therapy Product
Table 100. Arizant Healthcare Inc. Revenue in Infection Control in Cancer Therapy Business (2016-2021) & (US$ Million)
Table 101. Arizant Healthcare Inc. Recent Development
Table 102. Nordion Company Details
Table 103. Nordion Business Overview
Table 104. Nordion Revenue in Infection Control in Cancer Therapy Business (2016-2021) & (US$ Million)
Table 105. Nordion Recent Development
Table 106. Cisa S.P.A. Company Details
Table 107. Cisa S.P.A. Business Overview
Table 108. Cisa S.P.A. Infection Control in Cancer Therapy Product
Table 109. Cisa S.P.A. Revenue in Infection Control in Cancer Therapy Business (2016-2021) & (US$ Million)
Table 110. Cisa S.P.A. Recent Development
Table 111. Steris Corporation Company Details
Table 112. Steris Corporation Business Overview
Table 113. Steris Corporation Infection Control in Cancer Therapy Product
Table 114. Steris Corporation Revenue in Infection Control in Cancer Therapy Business (2016-2021) & (US$ Million)
Table 115. Steris Corporation Recent Development
Table 116. Nordion, Inc. Company Details
Table 117. Nordion, Inc. Business Overview
Table 118. Nordion, Inc. Infection Control in Cancer Therapy Product
Table 119. Nordion, Inc. Revenue in Infection Control in Cancer Therapy Business (2016-2021) & (US$ Million)
Table 120. Nordion, Inc. Recent Development
Table 121. Ahlstrom Filtration LLC Company Details
Table 122. Ahlstrom Filtration LLC Business Overview
Table 123. Ahlstrom Filtration LLC Infection Control in Cancer Therapy Product
Table 124. Ahlstrom Filtration LLC Revenue in Infection Control in Cancer Therapy Business (2016-2021) & (US$ Million)
Table 125. Ahlstrom Filtration LLC Recent Development
Table 126. Membrana GmbH Company Details
Table 127. Membrana GmbH Business Overview
Table 128. Membrana GmbH Infection Control in Cancer Therapy Product
Table 129. Membrana GmbH Revenue in Infection Control in Cancer Therapy Business (2016-2021) & (US$ Million)
Table 130. Membrana GmbH Recent Development
Table 131. Synergy Health, Plc Company Details
Table 132. Synergy Health, Plc Business Overview
Table 133. Synergy Health, Plc Infection Control in Cancer Therapy Product
Table 134. Synergy Health, Plc Revenue in Infection Control in Cancer Therapy Business (2016-2021) & (US$ Million)
Table 135. Synergy Health, Plc Recent Development
Table 136. Advanced Sterilization Products Services, Inc Company Details
Table 137. Advanced Sterilization Products Services, Inc Business Overview
Table 138. Advanced Sterilization Products Services, Inc Infection Control in Cancer Therapy Product
Table 139. Advanced Sterilization Products Services, Inc Revenue in Infection Control in Cancer Therapy Business (2016-2021) & (US$ Million)
Table 140. Advanced Sterilization Products Services, Inc Recent Development
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Infection Control in Cancer Therapy Market Share by Type: 2020 VS 2027
Figure 2. Radiation Therapy Features
Figure 3. Immunotherapy Features
Figure 4. Traditional Surgery Features
Figure 5. Stem Cell Transplant Therapy Features
Figure 6. Chemotherapy Features
Figure 7. Targeted Therapy Features
Figure 8. Photodynamic Therapy Features
Figure 9. Other Features
Figure 10. Global Infection Control in Cancer Therapy Market Share by Application: 2020 VS 2027
Figure 11. Hospital Case Studies
Figure 12. Pharmaceutical Companies Case Studies
Figure 13. Medical device companies Case Studies
Figure 14. Other Case Studies
Figure 15. Infection Control in Cancer Therapy Report Years Considered
Figure 16. Global Infection Control in Cancer Therapy Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 17. Global Infection Control in Cancer Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 18. Global Infection Control in Cancer Therapy Market Share by Regions: 2020 VS 2027
Figure 19. Global Infection Control in Cancer Therapy Market Share by Regions (2022-2027)
Figure 20. Global Infection Control in Cancer Therapy Market Share by Players in 2020
Figure 21. Global Top Infection Control in Cancer Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Infection Control in Cancer Therapy as of 2020
Figure 22. The Top 10 and 5 Players Market Share by Infection Control in Cancer Therapy Revenue in 2020
Figure 23. Global Infection Control in Cancer Therapy Revenue Market Share by Type (2016-2021)
Figure 24. Global Infection Control in Cancer Therapy Revenue Market Share by Type (2022-2027)
Figure 25. North America Infection Control in Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. North America Infection Control in Cancer Therapy Market Share by Type (2016-2027)
Figure 27. North America Infection Control in Cancer Therapy Market Share by Application (2016-2027)
Figure 28. North America Infection Control in Cancer Therapy Market Share by Country (2016-2027)
Figure 29. United States Infection Control in Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Canada Infection Control in Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Infection Control in Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Europe Infection Control in Cancer Therapy Market Share by Type (2016-2027)
Figure 33. Europe Infection Control in Cancer Therapy Market Share by Application (2016-2027)
Figure 34. Europe Infection Control in Cancer Therapy Market Share by Country (2016-2027)
Figure 35. Germany Infection Control in Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. France Infection Control in Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. U.K. Infection Control in Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Italy Infection Control in Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Russia Infection Control in Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Nordic Infection Control in Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Infection Control in Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Asia-Pacific Infection Control in Cancer Therapy Market Share by Type (2016-2027)
Figure 43. Asia-Pacific Infection Control in Cancer Therapy Market Share by Application (2016-2027)
Figure 44. Asia-Pacific Infection Control in Cancer Therapy Market Share by Region (2016-2027)
Figure 45. China Infection Control in Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Japan Infection Control in Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. South Korea Infection Control in Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Southeast Asia Infection Control in Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. India Infection Control in Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Australia Infection Control in Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Infection Control in Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Latin America Infection Control in Cancer Therapy Market Share by Type (2016-2027)
Figure 53. Latin America Infection Control in Cancer Therapy Market Share by Application (2016-2027)
Figure 54. Latin America Infection Control in Cancer Therapy Market Share by Country (2016-2027)
Figure 55. Mexico Infection Control in Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Brazil Infection Control in Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Infection Control in Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Middle East & Africa Infection Control in Cancer Therapy Market Share by Type (2016-2027)
Figure 59. Middle East & Africa Infection Control in Cancer Therapy Market Share by Application (2016-2027)
Figure 60. Middle East & Africa Infection Control in Cancer Therapy Market Share by Country (2016-2027)
Figure 61. Turkey Infection Control in Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Saudi Arabia Infection Control in Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. UAE Infection Control in Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 64. Kimberly Clark Corporation Revenue Growth Rate in Infection Control in Cancer Therapy Business (2016-2021)
Figure 65. 3M Healthcare Company Revenue Growth Rate in Infection Control in Cancer Therapy Business (2016-2021)
Figure 66. Honeywell International, Inc. Revenue Growth Rate in Infection Control in Cancer Therapy Business (2016-2021)
Figure 67. Getinge Group AB Revenue Growth Rate in Infection Control in Cancer Therapy Business (2016-2021)
Figure 68. Sterigenics International Revenue Growth Rate in Infection Control in Cancer Therapy Business (2016-2021)
Figure 69. Sakura Global Holding Company Revenue Growth Rate in Infection Control in Cancer Therapy Business (2016-2021)
Figure 70. Arizant Healthcare Inc. Revenue Growth Rate in Infection Control in Cancer Therapy Business (2016-2021)
Figure 71. Nordion Revenue Growth Rate in Infection Control in Cancer Therapy Business (2016-2021)
Figure 72. Cisa S.P.A. Revenue Growth Rate in Infection Control in Cancer Therapy Business (2016-2021)
Figure 73. Steris Corporation Revenue Growth Rate in Infection Control in Cancer Therapy Business (2016-2021)
Figure 74. Nordion, Inc. Revenue Growth Rate in Infection Control in Cancer Therapy Business (2016-2021)
Figure 75. Ahlstrom Filtration LLC Revenue Growth Rate in Infection Control in Cancer Therapy Business (2016-2021)
Figure 76. Membrana GmbH Revenue Growth Rate in Infection Control in Cancer Therapy Business (2016-2021)
Figure 77. Synergy Health, Plc Revenue Growth Rate in Infection Control in Cancer Therapy Business (2016-2021)
Figure 78. Advanced Sterilization Products Services, Inc Revenue Growth Rate in Infection Control in Cancer Therapy Business (2016-2021)
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed
がん幹細胞療法のグローバル市場調査 2019年 The global Cancer Stem Cell Therapy market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Cancer Stem Cell Therapy volume and value at global level, regional level and company level. From a global perspec…- 世界の肺がん治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Lung Cancer Therapy Market The global Lung Cancer Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report mak…
- 世界のがん点滴療法市場規模・現状・予測（2021年-2027年） Cancer treatments often require infusion treatments, like chemotherapy. Market Analysis and Insights: Global Cancer Infusion Therapy Market The global Cancer Infusion Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. Wi…
- 世界の強度変調放射線治療市場規模・現状・予測（2021年-2027年） Intensity modulated radiation therapy is a type of conformal radiotherapy for the treatment of cancer. Market Analysis and Insights: Global Intensity Modulated Radiation Therapy Market The global Intensity Modulated Radiation Therapy market size is projected to reach US$ XX million by 2027, from US$…
- 世界の胎盤幹細胞療法市場規模・現状・予測（2021年-2027年） Placental stem cells are cells derived from the placental blood and other body fluids of a new-born baby. Stem cells are human cells classified into a different variety of cell types, including brain and muscle cells. Stem cells are sometimes used in the development of regenerative therapies. Regene…